PE20140675A1 - Comprimido farmaceutico de liberacion controlada para administracion oral - Google Patents
Comprimido farmaceutico de liberacion controlada para administracion oralInfo
- Publication number
- PE20140675A1 PE20140675A1 PE2013001406A PE2013001406A PE20140675A1 PE 20140675 A1 PE20140675 A1 PE 20140675A1 PE 2013001406 A PE2013001406 A PE 2013001406A PE 2013001406 A PE2013001406 A PE 2013001406A PE 20140675 A1 PE20140675 A1 PE 20140675A1
- Authority
- PE
- Peru
- Prior art keywords
- polymer
- oral administration
- controlled release
- release pharmaceutical
- pharmaceutical tablet
- Prior art date
Links
- 238000013270 controlled release Methods 0.000 title abstract 2
- 229920000642 polymer Polymers 0.000 abstract 4
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 abstract 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 abstract 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 abstract 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 abstract 1
- 229920002301 cellulose acetate Polymers 0.000 abstract 1
- 229960003405 ciprofloxacin Drugs 0.000 abstract 1
- 229960003376 levofloxacin Drugs 0.000 abstract 1
- 229920000609 methyl cellulose Polymers 0.000 abstract 1
- YLGXILFCIXHCMC-JHGZEJCSSA-N methyl cellulose Chemical compound COC1C(OC)C(OC)C(COC)O[C@H]1O[C@H]1C(OC)C(OC)C(OC)OC1COC YLGXILFCIXHCMC-JHGZEJCSSA-N 0.000 abstract 1
- 239000001923 methylcellulose Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Physiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2010014153A MX2010014153A (es) | 2010-12-17 | 2010-12-17 | Comprimido farmaceutico de liberacion controlada para administracion oral. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20140675A1 true PE20140675A1 (es) | 2014-06-25 |
Family
ID=46245166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2013001406A PE20140675A1 (es) | 2010-12-17 | 2011-12-16 | Comprimido farmaceutico de liberacion controlada para administracion oral |
Country Status (11)
| Country | Link |
|---|---|
| BR (1) | BR112013014963A2 (fr) |
| CL (1) | CL2013001707A1 (fr) |
| CO (1) | CO6721021A2 (fr) |
| CR (1) | CR20130288A (fr) |
| DO (1) | DOP2013000136A (fr) |
| EC (1) | ECSP13012766A (fr) |
| GT (1) | GT201300154A (fr) |
| MX (1) | MX2010014153A (fr) |
| PE (1) | PE20140675A1 (fr) |
| RU (1) | RU2603469C2 (fr) |
| WO (1) | WO2012080984A2 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016058813A1 (fr) | 2014-10-16 | 2016-04-21 | Koninklijke Philips N.V. | Alignement d'un patient à l'intérieur d'un appareil d'imagerie par résonance magnétique |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL119627A (en) * | 1996-11-17 | 2002-03-10 | Yissum Res Dev Co | PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT |
| US6723340B2 (en) * | 2001-10-25 | 2004-04-20 | Depomed, Inc. | Optimal polymer mixtures for gastric retentive tablets |
| US20030104052A1 (en) * | 2001-10-25 | 2003-06-05 | Bret Berner | Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
| EP1455751A1 (fr) * | 2001-12-20 | 2004-09-15 | Pharmacia Corporation | Formes dosifiees a liberation soutenue d'ordre zero et procede de production associe |
-
2010
- 2010-12-17 MX MX2010014153A patent/MX2010014153A/es active IP Right Grant
-
2011
- 2011-12-16 RU RU2013127408/15A patent/RU2603469C2/ru active
- 2011-12-16 PE PE2013001406A patent/PE20140675A1/es active IP Right Grant
- 2011-12-16 WO PCT/IB2011/055720 patent/WO2012080984A2/fr not_active Ceased
- 2011-12-16 BR BR112013014963A patent/BR112013014963A2/pt not_active Application Discontinuation
-
2013
- 2013-06-13 CR CR20130288A patent/CR20130288A/es unknown
- 2013-06-13 CL CL2013001707A patent/CL2013001707A1/es unknown
- 2013-06-14 DO DO2013000136A patent/DOP2013000136A/es unknown
- 2013-06-17 GT GT201300154A patent/GT201300154A/es unknown
- 2013-06-18 CO CO13145004A patent/CO6721021A2/es unknown
- 2013-07-15 EC ECSP13012766 patent/ECSP13012766A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2010014153A (es) | 2012-06-18 |
| GT201300154A (es) | 2014-05-07 |
| RU2013127408A (ru) | 2015-01-27 |
| WO2012080984A2 (fr) | 2012-06-21 |
| ECSP13012766A (es) | 2013-09-30 |
| CR20130288A (es) | 2013-08-13 |
| BR112013014963A2 (pt) | 2016-09-13 |
| CO6721021A2 (es) | 2013-07-31 |
| RU2603469C2 (ru) | 2016-11-27 |
| DOP2013000136A (es) | 2013-10-15 |
| CL2013001707A1 (es) | 2014-01-10 |
| WO2012080984A3 (fr) | 2012-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1119798T1 (el) | Μορφη iv υδροχλωρικης ιβαμπραδινης | |
| EP4249055A3 (fr) | Formes pharmaceutiques orales de tofacitinib à libération prolongée | |
| EP2246052A4 (fr) | Comprimé à administration orale, à désintégration rapide, contenant de imidafénacine | |
| DK2925272T3 (da) | Lægemiddelopbevarings-, udleverings- og administrationssystem | |
| NZ605352A (en) | Process for producing glycosaminoglycans | |
| GT200600445A (es) | Formas de presentación farmaceuticas solidas de administración oral con liberacion rapida del principio activo. | |
| DOP2010000273A (es) | Preparacion solida de desintegracion oral | |
| AU2008347158A8 (en) | Oral pharmaceutical dosage forms | |
| LTPA2019508I1 (lt) | Vaistų pristatymo sistema, skirta sunkiai vandenyje tirpstančių, farmaciškai aktyvių medžiagų, pateikimui | |
| CY1118032T1 (el) | Διεργασιες για την εμπορικη παρασκευη φαρμακευτικα δραστικου παραγοντα | |
| EA201201202A1 (ru) | Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана | |
| MX2013001985A (es) | Formulaciones a base de nalbufina y sus usos | |
| JO3112B1 (ar) | تركيبة دوائية سريعة التحلل | |
| BR112013029199A2 (pt) | sistema de distribuição de fármacos, dispositivo de distribuição de dois fármacos, método para preparar o mesmo, comprimido para administração sublingual de um ingrediente ativo, e, método para a administração de um ingrediente ativo a um indivíduo | |
| EA201400737A1 (ru) | Система доставки на основе множества пеллет с немедленным высвобождением активного вещества | |
| PH12015500823A1 (en) | Modified release formulations for oprozomib | |
| CR20140358A (es) | Sistema para la administración de fármacos | |
| EA201291104A1 (ru) | Пероральные лекарственные формы бендамустина | |
| IT1401284B1 (it) | Nuove formulazioni farmaceutiche idonee per la somministrazione orale di esomeprazolo magnesio diidrato, in forma di compresse mups (multi unit pellets system). | |
| PE20140675A1 (es) | Comprimido farmaceutico de liberacion controlada para administracion oral | |
| CO6390098A2 (es) | Formulaciones de desintegración rapida pre-compactadas de compuestos con baja biodisponibilidad oral. | |
| MX2012007393A (es) | Composicion farmaceutica de disolucion rapida comprendiendo lornoxicam. | |
| WO2013054178A3 (fr) | Compositions pharmaceutiques à libération prolongée | |
| EA201992463A1 (ru) | Система доставки лекарственного средства | |
| ES2422657A1 (es) | Composición farmacéutica sólida de cilostazol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |